# The Epistemology of Silence: Establishing Symmetrical Evidence through the Open Negative Results Registry

> **A Foundational Document of the Dark Data Medicine Initiative**

---

## Abstract

The foundation of evidence-based medicine rests upon a critical, yet universally unacknowledged statistical fallacy: the asymmetric observation of trial outcomes. When the global scientific publishing ecosystem preferentially disseminates statistically significant findings while systematically omitting null or negative results, the scientific literature ceases to represent objective reality and instead becomes a curated manifestation of survivorship bias.

The **Open Negative Results Registry (ONRR)** seeks to fundamentally disrupt this paradigm by providing an immutable, publicly accessible, academically rigorous infrastructure for preserving and indexing **Dark Data**. Through the systematic registration of negative and null findings, the registry aims to restore symmetry to empirical evidence, reduce the enormous economic burden of redundant research, strengthen reproducibility, and fulfill the ethical obligations owed to human research participants.

---

# 1. The Statistical Asymmetry of Modern Medicine

Modern scientific publishing operates under a profound selection bias.

Let

- $\Omega$ denote the universe of all rigorously conducted scientific studies.
- $\Phi$ denote the subset of studies that ultimately become published.

In an unbiased scientific ecosystem,

$$
\Phi \subset \Omega
$$

should represent an approximately random sample of all completed studies.

Instead, publication probability is strongly conditioned on statistical significance.

Let

- $E_p$ represent **positive evidence**, where the null hypothesis ($H_0$) is rejected (typically $p < 0.05$).
- $E_n$ represent **negative or null evidence**, where $H_0$ cannot be rejected.

A scientifically symmetrical publication system would satisfy

$$
P(\text{Publication}\mid E_p)
\approx
P(\text{Publication}\mid E_n)
$$

Empirical evidence demonstrates precisely the opposite:

$$
P(\text{Publication}\mid E_p)
\gg
P(\text{Publication}\mid E_n)
$$

This asymmetry fundamentally distorts scientific knowledge.

Systematic reviews and meta-analyses estimate the true intervention effect size ($\theta$) using only the observable literature. When null evidence ($E_n$) is systematically absent, statistical estimation becomes biased, inevitably leading to:

- inflated estimates of therapeutic efficacy,
- underestimated adverse effects,
- unnecessary duplication of failed experiments,
- distorted funding priorities.

The Open Negative Results Registry is explicitly designed to restore statistical symmetry by preserving the missing component of scientific evidence: **negative results**.

---

# 2. The Ontology of Dark Data

Within the Dark Data Medicine framework, **Dark Data** is defined as:

> Scientifically valid evidence that remains absent from the public scientific record despite being generated through rigorous research.

Dark Data is **not failed science**.

It is **successful science that produced a null outcome.**

A properly designed experiment demonstrating that a treatment **does not work** possesses epistemological value equal to one demonstrating that it **does work**.

The registry prioritizes three principal categories of Dark Data.

## 2.1 Orphaned Preclinical Hypotheses

Preclinical experiments—including in vitro and animal studies—that invalidate proposed biological mechanisms before clinical development.

Preserving these findings prevents redundant laboratory efforts across institutions investigating identical hypotheses.

---

## 2.2 Phase I and Phase II Clinical Stagnations

Early-stage clinical trials terminated because of:

- futility,
- lack of efficacy,
- insufficient biological activity,
- strategic discontinuation.

Many such studies never enter publicly searchable databases despite containing scientifically valuable evidence.

---

## 2.3 Secondary Endpoint Failures

Published clinical trials frequently emphasize statistically significant primary endpoints while omitting non-significant secondary or exploratory outcomes.

These omitted observations represent hidden evidence capable of substantially influencing future systematic reviews and hypothesis generation.

---

# 3. The Economic and Ethical Imperative

Suppressing negative evidence is not merely a scientific inefficiency.

It represents both an economic loss and an ethical failure.

## Economic Impact

When null evidence remains inaccessible, independent research groups unknowingly replicate previously unsuccessful hypotheses.

This duplication consumes:

- funding,
- laboratory resources,
- investigator time,
- computational infrastructure,
- clinical trial capacity.

Collectively, irreproducible and redundant biomedical research is estimated to cost **tens of billions of dollars annually**.

The preservation of negative findings therefore represents an investment in global research efficiency rather than an administrative burden.

---

## Bioethical Responsibility

The **Declaration of Helsinki** establishes that human participants volunteer for research to advance collective scientific knowledge.

When valid clinical evidence is deliberately withheld because it lacks commercial or academic appeal, that ethical contract is violated.

Negative findings are not optional scientific artifacts.

They constitute part of the knowledge participants consented to create.

The systematic preservation of these findings therefore represents an ethical obligation toward every participant enrolled in biomedical research.

---

# 4. Methodological Framework for Symmetrical Registration

The Open Negative Results Registry operationalizes evidence symmetry through standardized, machine-readable metadata.

Every submission is validated against a versioned JSON Schema to ensure:

- consistency,
- interoperability,
- reproducibility,
- computational accessibility.

The registry captures, among other variables:

- statistical power ($1-\beta$),
- confidence intervals ($CI$),
- effect size estimates (Cohen's $d$, Odds Ratios, Hazard Ratios),
- methodological characteristics,
- study design,
- intervention metadata,
- outcome classification.

This structured representation transforms negative evidence from isolated narrative reports into computationally usable scientific knowledge.

Consequently, modern analytical systems—including artificial intelligence and machine-learning pipelines—can incorporate negative findings during model training.

Such integration creates opportunities to identify high-risk research trajectories before significant financial or human resources are committed.

---

# 5. Declaration of Intent

The Open Negative Results Registry affirms that the absence of statistical significance is not the absence of scientific value.

Negative evidence is an indispensable component of cumulative scientific knowledge.

Every documented null result reduces uncertainty.

Every recorded failure narrows the search space of future discovery.

Every preserved experiment prevents future researchers from repeating avoidable mistakes.

We therefore invite:

- researchers,
- principal investigators,
- clinical sponsors,
- funding agencies,
- publishers,
- universities,
- research institutions,

to participate in building a scientific ecosystem founded upon **symmetrical evidence** rather than selective visibility.

By contributing negative findings to this repository, researchers do not acknowledge failure.

They illuminate the landscape of scientific inquiry—marking unproductive paths so that future generations may advance with greater precision, greater efficiency, and greater integrity.

---

## Citation

> Pleșca, C. Ș. (2026). *The Epistemology of Silence: Establishing Symmetrical Evidence through the Open Negative Results Registry*. Dark Data Medicine Initiative.

---

## Keywords

Dark Data, Publication Bias, Negative Results, Null Results, Open Science, Evidence-Based Medicine, Meta-analysis, Reproducibility, FAIR Data, Biomedical Research, Research Waste, Clinical Trials, Scientific Integrity, Open Negative Results Registry